Dr. Antony is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
U of MI Med Sch
Ann Arbor, MI 48109- Is this information wrong?
Education & Training
University of Michigan Medical SchoolClass of 2000
Publications & Presentations
PubMed
- 6 citationsPD-L1–Independent Mechanisms Control the Resistance of Melanoma to CD4+ T Cell Adoptive ImmunotherapyStephen R. Goding, Kyle A. Wilson, Carolyn Rosinsky, Paul A. Antony> ;Journal of Immunology. 2018 May 1
- 10 citations17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model.Sandeep S. Joshi, Shunlin Jiang, Emmanual Unni, Stephen R. Goding, Tao Fan, Paul A. Antony, Thomas J. Hornyak> ;Plos One. 2018 Feb 26
- 147 citationsRestoring Immune Function of Tumor-Specific CD4 + T Cells during Recurrence of MelanomaStephen R. Goding, Kyle A. Wilson, Ying Xie, Kristina M. Harris, Aparna Baxi, Akgul Akpinarli, Amy M. Fulton, Koji Tamada, Scott E. Strome, Paul A. Antony> ;Journal of Immunology. 2013 May 1
Grant Support
- The Role Of Antigen-Specific CD4+ T Cells During Immunity To Established TumorsNational Cancer Institute2007–2009
- The Role Of Antigen-Specific CD4+ T Cells During Immunity To Established TumorsNational Cancer Institute2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
